Brussels, 10/04/2001 (Agence Europe) - The European Commission will be re-examining the anti-dumping measures for coumarin imports (warfarin) from China, which ran out on 4 April 2001. The only European warfarin manufacturer has provided the European Commission with sufficient evidence to justify concerns that China may be continuing or planning to continue the dumping that had given rise to the original ruling. According to the European company (whose identity was not revealed in the notice published in the Official Journal, C104), China is continuing to dump large quantities of warfarin and this may well increase if new measures are not taken, given China's currently unused manufacturing capacity, its protected trade measures restricting access to other uses of the substance and well-established trading networks in the European Community. The Commission believes at this stage that "these elements may lead to a re-orienting of China's exports toward the Community" and will be assessing the dangers to EU industry of a rise in imports from China. The European manufacturer argues that it would lose a substantial market share, suffer downward price pressure and therefore a loss of profits if the anti-dumping measures (which have been in place since 1996) are not extended.